Ten new iridoid glycosides (1-10) and two new monoterpenoids (11 and 12), together with nine known compounds (13-21), were isolated from the n-butanol extract of the aerial parts of Anarrhinum pedatum. The structural characterization of all compounds was performed by spectroscopic analysis, including 1D and 2D NMR, and HRESIMS experiments. The isolates were assayed for their antiangiogenic activity by two in vivo models, using zebrafish embryos and chicken chorioallantoic membranes (CAMs). The results showed that among the new compounds, 6'-O-menthiafoloylmussaenosidic acid-11-(5-O-β-D-fructopyranosyl) ester (9), exhibited the most potent antiangiogenic activity in both the zebrafish embryos and CAM assays, reducing the growth of blood vessels. Antiangiogenic effects were also observed for the known compounds, 6-O-nerol-8-oyl-antirrinoside (13), antirrinoside (14), 6-O-trans and cis-p-coumaroyl antirrinoside (15), and (6S)-2E-2,6-dimethyl-6-hydroxyocta-2,7-dienoic acid β-glucopyranosyl ester (18).

Antiangiogenic Activity of Compounds Isolated from Anarrhinum pedatum

F. D’Andrea;A. Braca
;
M. De Leo
Ultimo
2019-01-01

Abstract

Ten new iridoid glycosides (1-10) and two new monoterpenoids (11 and 12), together with nine known compounds (13-21), were isolated from the n-butanol extract of the aerial parts of Anarrhinum pedatum. The structural characterization of all compounds was performed by spectroscopic analysis, including 1D and 2D NMR, and HRESIMS experiments. The isolates were assayed for their antiangiogenic activity by two in vivo models, using zebrafish embryos and chicken chorioallantoic membranes (CAMs). The results showed that among the new compounds, 6'-O-menthiafoloylmussaenosidic acid-11-(5-O-β-D-fructopyranosyl) ester (9), exhibited the most potent antiangiogenic activity in both the zebrafish embryos and CAM assays, reducing the growth of blood vessels. Antiangiogenic effects were also observed for the known compounds, 6-O-nerol-8-oyl-antirrinoside (13), antirrinoside (14), 6-O-trans and cis-p-coumaroyl antirrinoside (15), and (6S)-2E-2,6-dimethyl-6-hydroxyocta-2,7-dienoic acid β-glucopyranosyl ester (18).
2019
Beladjila, K. A.; Berrehal, D.; Kabouche, Z.; Germanò, M. P.; D’Angelo, V.; De Tommasi, N.; D’Andrea, F.; Braca, A.; De Leo, M....espandi
File in questo prodotto:
File Dimensione Formato  
APD.pdf

solo utenti autorizzati

Tipologia: Versione finale editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 3.67 MB
Formato Adobe PDF
3.67 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
APD paper revised 25 febbraio.pdf

accesso aperto

Tipologia: Documento in Post-print
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 393.18 kB
Formato Adobe PDF
393.18 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/992542
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 9
social impact